You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

thrombopoietin (TPO)-receptor agonist

Showing 1 - 25 of 8,314
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Immune Thrombocytopenia (ITP) Trial (Ianalumab)

Not yet recruiting
  • Primary Immune Thrombocytopenia (ITP)
  • Ianalumab
  • (no location specified)
Jun 5, 2023

Poor Graft Function Trial (decitabine, umbilical cord blood, Granulocyte-colony stimulating factor)

Not yet recruiting
  • Poor Graft Function
  • (no location specified)
Dec 29, 2022

MDS, Thrombocytopenia Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Eltrombopag)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Thrombocytopenia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 8, 2022

Stem Cell Transplant Complications Trial in Suzhou (Eltrombopag 25 MG Oral Tablet, Thrombopoietin)

Not yet recruiting
  • Stem Cell Transplant Complications
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jul 17, 2022

Moderate Aplastic Anemia, Unilineage Bone Marrow Failure Disorders Trial run by the NHLBI (Eltrombopag)

Active, not recruiting
Has Results
  • Moderate Aplastic Anemia
  • Unilineage Bone Marrow Failure Disorders
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 2, 2021

Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP

Not yet recruiting
  • Thrombopoietin Receptor Agonist
    • (no location specified)
    May 4, 2023

    Anemia, Aplastic, Anemia, Hypoplastic, Thrombocytopenia Trial run by the NHLBI (Eltrombopag)

    Completed
    Has Results
    • Anemia, Aplastic
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Sep 30, 2020

    Aplastic Anemia, CSA, Drug Therapy Trial in Beijing (CsA+ATG+Herombopag, CsA+Herombopag)

    Recruiting
    • Aplastic Anemia
    • +2 more
    • Beijing, China
      Peking union medical college hospital
    Aug 20, 2023

    Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia,

    Recruiting
    • Autoimmune Hemolytic Anemia
    • +5 more
    • cytokine essays
    • +6 more
    • Milano, Italy
      Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico
    Jul 3, 2023

    Poor Graft Function Trial (Decitabine, Granulocyte Colony-Stimulating Factor, Thrombopoietin Receptor Agonist)

    Not yet recruiting
    • Poor Graft Function
    • (no location specified)
    Jun 8, 2023

    Thrombopoietin Agonists in Idiopathic Thrombocytopenic Purpura

    Not yet recruiting
    • ITP - Immune Thrombocytopenia
    • eltrombopag and romiplastim
    • (no location specified)
    Nov 16, 2023

    Immune Thrombocytopenia Trial (Herombopag)

    Not yet recruiting
    • Immune Thrombocytopenia
    • (no location specified)
    Jan 13, 2023

    Lymphoma, Peripheral Blood Stem Cell Transplantation Trial (Eltrombopag olamine)

    Not yet recruiting
    • Lymphoma
    • Peripheral Blood Stem Cell Transplantation
    • Eltrombopag olamine
    • (no location specified)
    Jul 25, 2023

    Primary Immune Thrombocytopenia (ITP) Trial in Tianjin (TPO-RAs, TPO-RAs combining anti-CD 20 mAb)

    Not yet recruiting
    • Primary Immune Thrombocytopenia (ITP)
    • TPO-RAs
    • TPO-RAs combining anti-CD 20 monoclonal antibody
    • Tianjin, China
      Institute of Hematology and Blood Diseases Hospital, Chinese Aca
    Feb 7, 2023

    Immune Thrombocytopenia Trial in Switzerland (romiplostim)

    Completed
    • Immune Thrombocytopenia
    • Liestal, Basel-Land, Switzerland
    • +4 more
    May 6, 2020

    Hematological Disease, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Tianjin (Hetrombopag, )

    Recruiting
    • Hematological Disease
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital, Chinese Acade
    Feb 6, 2023

    Gastrointestinal Cancer, Gastrointestinal Tumors, Chemo-Induced Thrombocytopenia Trial in Miami, Boston (Avatrombopag, Matching

    Not yet recruiting
    • Gastrointestinal Cancer
    • +2 more
    • Miami, Florida
    • +1 more
    Mar 6, 2023

    Primary Immune Thrombocytopenia (ITP) Trial in Switzerland (Eltrombopag (Revolade®), standard therapy (without eltrombopag):

    Recruiting
    • Primary Immune Thrombocytopenia (ITP)
    • Eltrombopag (Revolade®)
    • standard therapy (without eltrombopag): HD-DXM
    • Aarau, Switzerland
    • +5 more
    Sep 5, 2022

    Persistent or Chronic ITP Trial in Creteil (Tpo-RA discontinuation)

    Unknown status
    • Persistent or Chronic ITP
    • Tpo-RA discontinuation
    • Creteil, France
      Henri-Mondor Hospital
    Feb 17, 2020

    Eltrombopag and Recombinant Human Thrombopoietin In Primary

    Unknown status
    Has Results
    • Corticosteroid-resistant or Relapsed ITP
    • Beijing, Beijing, China
      Peking University Institute of Hematology
    Oct 17, 2020

    Aplastic Anemia Trial in Beijing (Ciclosporin, Avatrombopag, Anti-Human Thymocyte Immunoglobulin, Rabbit)

    Not yet recruiting
    • Aplastic Anemia
    • Beijing, China
      Peking union medical college hospital
    Aug 16, 2023

    CLL, Leukemia Trial in Houston (Eltrombopag)

    Completed
    • CLL
    • Leukemia
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Mar 14, 2022

    Bone Marrow Failure Disorders, Aplastic Anemia, Thrombocytopenia Trial in Iowa City (Romiplostim)

    Recruiting
    • Bone Marrow Failure Disorders
    • +4 more
    • Iowa City, Iowa
      University of Iowa Hospitals & Clinics
    Jun 4, 2021

    A Study of Switching Avatrombopag and Rh-TPO in ITP

    Not yet recruiting
    • Corticosteroid-resistant or Relapsed ITP
      • (no location specified)
      May 29, 2021

      Breast Cancer Trial in Zhengzhou (Hetrombopag, rh-TPO)

      Not yet recruiting
      • Breast Cancer
      • Zhengzhou, Henan, China
        Henan Cancer Hospital
      May 26, 2022